» Articles » PMID: 28490910

Optimizing Psychosocial Interventions in First-episode Psychosis: Current Perspectives and Future Directions

Overview
Publisher Dove Medical Press
Specialty Social Sciences
Date 2017 May 12
PMID 28490910
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Psychotic-spectrum disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder with psychotic features are devastating illnesses accompanied by high levels of morbidity and mortality. Growing evidence suggests that outcomes for individuals with psychotic-spectrum disorders can be meaningfully improved by increasing the quality of mental health care provided to these individuals and reducing the delay between the first onset of psychotic symptoms and the receipt of adequate psychiatric care. More specifically, multicomponent treatment packages that 1) simultaneously target multiple symptomatic and functional needs and 2) are provided as soon as possible following the initial onset of psychotic symptoms appear to have disproportionately positive effects on the course of psychotic-spectrum disorders. Yet, despite the benefit of multicomponent care for first-episode psychosis, clinical and functional outcomes among individuals with first-episode psychosis participating in such services are still suboptimal. Thus, the goal of this review is to highlight putative strategies to improve care for individuals with first-episode psychosis with specific attention to optimizing psychosocial interventions. To address this goal, we highlight four burgeoning areas of research with regard to optimization of psychosocial interventions for first-episode psychosis: 1) reducing the delay in receipt of evidence-based psychosocial treatments; 2) synergistic pairing of psychosocial interventions; 3) personalized delivery of psychosocial interventions; and 4) technological enhancement of psychosocial interventions. Future research on these topics has the potential to optimize the treatment response to evidence-based psychosocial interventions and to enhance the improved (but still suboptimal) treatment outcomes commonly experienced by individuals with first-episode psychosis.

Citing Articles

Intervention Programmes for First-Episode Psychosis: A Scoping Review.

Gouveia M, Morgado T, Costa T, Sampaio F, Rosa A, Sequeira C Nurs Rep. 2025; 15(1).

PMID: 39852638 PMC: 11767625. DOI: 10.3390/nursrep15010016.


A Systematic Review of Resilience in At-Risk Youth for Psychotic Disorders: An Analysis of Protective and Risk Factors from Recent Literature.

Cojocaru A, Braha A, Anastasescu C, Folescu R, Bugi M, Puiu M Behav Sci (Basel). 2024; 14(10).

PMID: 39457770 PMC: 11505514. DOI: 10.3390/bs14100898.


Working memory performance is related to childhood trauma but not psychotic-like experiences in a nonpsychiatric sample.

Ered A, Chun C, OBrien K, Creatura G, Ellman L Psychol Trauma. 2023; 16(8):1357-1366.

PMID: 37561443 PMC: 10858292. DOI: 10.1037/tra0001568.


Recruitment, attrition and intervention completion in clinical trials of psychosocial interventions involving people with early and emerging psychosis: a systematic review protocol.

Easpaig B, Zhai J, Gray R, Brown E, Bressington D BMJ Open. 2023; 12(9):e060863.

PMID: 36691180 PMC: 9454042. DOI: 10.1136/bmjopen-2022-060863.


Growth of Coordinated Specialty Care in the United States With Changes in Federal Funding Policies: 2014-2018.

George P, Ghose S, Goldman H, OBrien J, Daley T, Dixon L Psychiatr Serv. 2022; 73(12):1346-1351.

PMID: 35707858 PMC: 9722492. DOI: 10.1176/appi.ps.202100600.


References
1.
Rosenheck R, Mueser K, Sint K, Lin H, Lynde D, Glynn S . Supported employment and education in comprehensive, integrated care for first episode psychosis: Effects on work, school, and disability income. Schizophr Res. 2016; 182:120-128. DOI: 10.1016/j.schres.2016.09.024. View

2.
Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F . Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013; 382(9896):951-62. DOI: 10.1016/S0140-6736(13)60733-3. View

3.
Laursen T, Nordentoft M, Mortensen P . Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2013; 10:425-48. DOI: 10.1146/annurev-clinpsy-032813-153657. View

4.
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz W . World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry. 2012; 13(5):318-78. DOI: 10.3109/15622975.2012.696143. View

5.
Vesterager L, Christensen T, Olsen B, Krarup G, Forchhammer H, Melau M . Cognitive training plus a comprehensive psychosocial programme (OPUS) versus the comprehensive psychosocial programme alone for patients with first-episode schizophrenia (the NEUROCOM trial): a study protocol for a centrally randomised,.... Trials. 2011; 12:35. PMC: 3046899. DOI: 10.1186/1745-6215-12-35. View